Delayed Release vs Enteric Coated Capsules: 重要な違い, Manufacturing Routes & 選び方

遅延放出カプセル そして 腸溶性カプセル are related but not identical. “Delayed-release” is a broad pharmaceutical category for any design that postpones drug release, while “enteric-coated” refers specifically to a pH-sensitive polymer barrier. 実際に, all enteric-coated capsules are delayed-release, but delayed-release products can use other triggers (時間, 酵素, 等). Manufacturers can achieve delayed release by:

1. coating a filled capsule with enteric polymer.
2. using a ready-to-fill enteric-resistant capsule shell.
3. filling capsules with enteric-coated pellets or granules.
4. combining immediate- and delayed-release particles.

Each route has trade-offs in equipment, 柔軟性, そして複雑さ. 例えば, enteric-coated pellets allow multiple release phases in one capsule, but require precise pellet dosing on the カプセル充填機. Key production considerations include capsule shell compatibility (gelatin vs HPMC), coating adhesion, and fill equipment settings. We compare each approach below to help you select the right strategy for your formulation.

What Are Delayed-Release, Extended-Release and Enteric-Coated Capsules?

「Delayed-release (DR)” is a general term for any oral dosage form engineered to hold its contents for a period after ingestion. 言い換えると, それ コントロール いつ the drug is released. 例えば, an HPMC (ヒドロキシプロピルメチルセルロース) capsule with an extra-thick wall may dissolve more slowly, delaying the release of its API. The goal is often to reduce stomach irritation or target delivery to a later point in the GI tract.

アン 腸溶性コーティングされた (Acid-Resistant) capsule is one specific way to achieve delayed release. “Enteric” means intestine. These capsules are given a specialized polymer coating that is insoluble in stomach acid but soluble at higher pH (the small intestine). 実際に, the capsule stays intact in the stomach (pH ~1.5 ～ 3.5) and only dissolves when it reaches the small intestine (pH ~6.0–7.5). This precisely controls どこ the drug releases. 腸溶性コーティング protect acid-labile drugs (例えば. PPIs like omeprazole) and also protect the stomach lining from irritants (例えば. アスピリン).

延長リリース (は) カプセル: Forms that release drug slowly over an extended period (時間) to maintain steady blood levels. Not the same as delayed release. ER systems (hydrophilic matrices, 浸透圧ポンプ, 等) control the rate of release from the moment of ingestion, rather than imposing an initial lag. 例えば, an ER capsule might gradually release drug over 8–24 hours. Delayed release simply imposes a delay, whereas extended release modulates release rate (または両方).

要するに, all enteric-coated capsules are delayed-release, but not all delayed-release capsules are enteric-coated. Delayed-release covers any mechanism (thicker shell, polymer matrix, ビーズ, 等) that shifts the release profile. Enteric-coated is the most common method, using pH-dependent coatings. Both ensure drugs aren’t released immediately, but delayed-release focuses on timing, while enteric-coated focuses on bypassing the stomach.

Key Differences at a Glance

The table below summarizes the major differences between delayed-release and enteric-coated capsules:

This table captures the core contrasts. Delayed-release “postpones” release based on material and thickness, while enteric capsules add a chemical barrier that only dissolves at intestinal pH. 実務的には, use delayed-release if the goal is タイミング (例えば. reduce reflux or provide convenience) and use enteric-coated if the API is acid-sensitive or targeted to the intestines.

How Delayed-Release and Enteric Coatings Work

At a mechanistic level, delayed-release capsules often rely on the カプセルシェル itself and fillers:

• Delayed-Release Capsules: These commonly use HPMC (plant-derived) カプセルシェル that dissolve more slowly than gelatin. HPMC is a bulky polymer, so an HPMC capsule (especially larger sizes or multiple layers) inherently gives a lag time. 場合によっては, delayed release can also be achieved by filling a capsule with pellets or granules that are coated with slow-release polymers, or by formulating the capsule with release-slowing excipients (例えば. hydrophobic waxes). 本質的には, the “trigger” can be time-based or material-based. HPMC shells that extend gastric residence, delaying release of ingredients like fish oils or botanicals.
• Enteric Coating Technology: 対照的に, an enteric-coated capsule uses a pH-sensitive polymer film. Enteric polymers (like cellulose acetate phthalate, HPMC phthalate, or methacrylate copolymers such as Eudragit L/S) are chosen because they won’t dissolve in stomach acid but will dissolve in the higher pH of the duodenum. 製造業において, either the capsule shell itself is made from or lined with these polymers, or a conventional capsule is spray-coated with an enteric polymer solution/dry powder. The coating typically contains plasticizers (例えば. クエン酸トリエチル, ペグ) to make it flexible.

The science: gastric pH (~1–3) keeps the film intact (no release), but once the capsule passes to the small intestine (pH ~6–7), the enteric film swells and dissolves, liberating the drug. 例えば, omeprazole is formulated as a delayed-release capsule と 腸溶性コーティング; without the coating it would be destroyed by stomach acid.

要約すれば, delayed-release encapsulates the broad concept (“hold the drug back”), whereas enteric coating is the technology to achieve that for stomach-sensitive cases.

Common APIs and Applications

Delayed-Release Capsule Examples: Delayed-release capsules are often used for ingredients that benefit from a lag but are not damaged by acid. 一般的な例としては、次のようなものがあります。 オメガ3オイル or certain botanicals which can cause reflux if released immediately. Some probiotics (acid-tolerant strains) or peptides fall here if you only need to reduce dose frequency or stomach upset. 本質的には, if the API irritates the stomach (like an NSAID) but isn’t itself acid-sensitive, delayed-release can improve tolerance.

Enteric-Coated Capsule Examples: Enteric-coated capsules are chosen for acid-labile drugs and targeted GI delivery. Classic examples: プロトンポンプ阻害剤 (オメプラゾール, esomeprazole) and other stomach-acid-sensitive drugs, digestive enzymes (例えば. pancrelipase for cystic fibrosis), そしてプロバイオティクス (so the bacteria survive to the gut). They’re also used for vitamins/herbals when needed (例えば. SAMe supplements) and some rectally-targeted medications. Many OTC aspirin or ibuprofen products have “enteric-coated” versions to protect the stomach lining. 鍵となるのは: if your API or ingredient is inactivated or irritating in acid, enteric is the way to go.

材料, Excipients and Polymers

• Capsule Shell Materials: Hard capsules are typically gelatin or HPMC. For delayed-release, HPMC シェル (ベジタリアン) are common because they dissolve slower and can be plant-derived. Enteric capsules may use standard shells but must be coated with enteric polymer, or use specially formulated shells. Some companies also produce ready-to-fill enteric capsules to skip the coating step.
• Enteric Polymers: Traditional polymers include cellulose acetate phthalate (キャップ) and various cellulose esters (HPMCP, HPMCAS). Methacrylate copolymers (オイドラギット・L, S, L30D, 等) are widely used and can dissolve around pH 5.5–7.0. Natural resins like shellac, どれの, and alginates also provide acid resistance, often in nutraceuticals.
• 可塑剤: Enteric films need plasticizers like triethyl citrate, グリセリン, or polyethylene glycol to avoid cracking. Hydrophobic plasticizers (例えば. TEC, acetyl tributyl citrate) help maintain acid resistance, while hydrophilic ones can inadvertently increase water uptake.
• Other Fill Excipients: The capsule fill (薬 + 賦形剤) may include fillers (微結晶セルロース, 乳糖), 潤滑剤 (ステアリン酸マグネシウム), 流動補助剤 (コロイダルシリカ), および崩壊剤 (クロスポビドン) in any capsule. For enteric capsules, ensure excipients are compatible with acid–alkaline transitions.

Four Manufacturing Routes for Delayed-Release Capsules

Pharmaceutical manufacturers have several routes to create a delayed-release capsule. Below is an overview of four common approaches, from most to least traditional. Each route has a different process flow, equipment need, と柔軟性:

形: Four main routes to achieve delayed-release capsules. ルート 1 coats the filled capsule; ルート 2 uses a ready-to-fill enteric shell; ルート 3 fills with enteric-coated pellets; ルート 4 (not shown) is a combination of pellets with other formats.

• ルート 1: Enteric-Coat the Filled Capsule. Fill a standard capsule (ゼラチンまたはHPMC) with your API formulation (粉, 顆粒, ペレット, 等), lock/seal it, and then put the whole capsule into a pan or fluid-bed coater. The entire capsule is coated with an enteric polymer (例えば. Eudragit®, HPMCP, キャップ, 等). This is the most traditional method. It ensures the shell and cap are covered, but requires an extra coating process, drying time, and possible capsule shrinkage. The benefit is strong acid protection conforming to pharmacopeia. The downside is extra cost and processing – you now have 3 unit operations (充填, 封印, コーティング). Capsule bands or seals might also be needed to prevent cap-body separation under coating conditions.
• ルート 2: Use a Functional Enteric Capsule Shell. Instead of starting with a normal shell, を使用します pre-formed enteric capsule from suppliers. These are two-piece hard capsules made of HPMCP, HPMCAS, キャップ, or other enteric polymers. You simply fill and seal them like ordinary capsules. No coating step is needed. This greatly simplifies production: the acid-resistant property is built into the shell. ある業界のレビューメモとして, ready-to-fill enteric capsules can reduce the process to “only one manufacturing step,” saving development time and avoiding heat/moisture exposure of a coating step. しかし, you must source the special shells (より高いコスト) and validate them. Not all APIs can be directly filled (粘度, 粘着性). 例: EUDRACAP® (Evonik) capsules use an HPMC shell pre-coated with Eudragit®, offering ~4 hours of acid resistance.
• ルート 3: Fill with Enteric-Coated Pellets or Granules. ここ, the capsule shell itself can be a normal gelatin or HPMC shell (no special properties). The acid-resistant barrier is achieved by coating ペレット, granules or mini-tablets of the drug with enteric polymers before filling. 実際に, you would (1) 粒状にする or pelletize the API, (2) coat those pellets in an enteric film coater, それから (3) fill the finished coated pellets into capsules. This is common in modified-release products. 例えば, one can encapsulate enteric-coated aspirin pellets in a capsule. The advantage is great flexibility: you can mix pellets with different coatings to create multiple release profiles. また, capsule filling equipment can be standard. The downside: you need a whole pellet-coating process (another coating/drying step), and filling many small pellets requires precise dosing (machines need pellet-feeding attachments). Uniform pellet count and protecting the fragile coating during filling are key challenges. But this route avoids coating the capsule itself and can be scaled from lab to production.
• ルート 4: Multiparticulate Combination Filling. A more specialized option is to combine different components in one capsule: 例えば。, some immediate-release powder or mini-tablets plus some enteric-coated pellets. This can create a product that has, 言う, a first-dose flush (即時解放) and then a delayed-release portion. It might require capsule-filling machines with multiple dosing stations (one for powder, one for pellets, 等). This approach is mostly used when you want a biphasic or multiphasic release, but it adds complexity. The advantage is ultimate flexibility: you can fine-tune ratios.

Each route requires appropriate downstream steps. 例えば, all routes above except Route 2 include a standard capsule locking/finishing step. Routes 1 そして 3 both include a dedicated enteric-coating operation (on capsules or pellets). ルート 2 may use a simple sealing machine if special shells come pre-gelled. See the Mermaid chart for flows.

Coating Equipment

• Pan Coaters: The classic コーティングマシン is a rotating perforated pan (Drum Coater) where capsules tumble inside while a fine spray applies the polymer solution. Modern models have heated air to dry quickly.
• Fluidized-Bed/ Wurster Coaters: These suspend capsules in a stream of air and spray from below, giving very even coats. ウルスター (ボトムスプレー) is common for small batches or particles.
• Automatic Capsule Fillers: For both types, large-scale production uses automatic capsule-filling machines which align, 埋める, and lock capsules rapidly. For enteric processes, machines may have gentle closing stations to avoid damaging fragile shells.

  

Each piece of equipment must be validated for uniformity. High-shear spray nozzles and precise temperature/humidity control are critical to avoid defects (例えば. “orange peel” surface, ひび割れ).

Quality Control and Testing

QC is crucial for both capsule types. 主要なテストには以下が含まれます:

• コンテンツの均一性: Ensuring each capsule holds the correct dose (by weight or assay).
• 溶解試験: For delayed-release capsules, test in appropriate media to confirm delayed-release profile. For enteric capsules, USP tests usually require no drug release in 0.1N HCl for 2 時間, followed by release in pH 6.8 バッファ. Instruments like USP apparatus 2 (パドル) or apparatus 1 (basket) 使用されています.
• 崩壊: Enteric forms must meet compendial disintegration: no break-down in 0.1N HCl for typically 1–2 hours, then pass in pH 6.8.
• 水分含有量: HPMC capsules have low moisture (<10%); gelatin capsules ~12–15%. Moisture affects hardness, so measure with Karl Fischer titration.
• 安定性試験: As with any dosage form, perform accelerated stability (例えば. 40℃/75%相対湿度) and shelf-life studies. Coated capsules may have additional sensitivity (some enteric polymers are hygroscopic), so monitor drug potency and coat integrity over time.

According to Kolmar’s overview, “rigorous testing is conducted to ensure each batch meets industry standards for content uniformity, 解散, and stability”. 実際に, especially for enteric-coated forms, the combined disintegration/dissolution test is paramount.

Scale-Up Considerations

When scaling production from lab to commercial batches:

• Coating Scale-Up: The spray rate, パンスピード, and drying airflow often need re-optimization. Film quality must remain consistent; larger pans may require slower coating to avoid “hot spots” and thickness variation. The rule of thumb is to keep the coating weight gain (percentage of added polymer) 一貫性のある, and always verify uniformity.
• Equipment Differences: Small machines may use different spray guns or mixers than large ones. Always re-validate process parameters (例えば. inlet air temp, spray atomization pressure) at scale.
• Process Time: Coating large batches can take hours (以上), affecting throughput. Efficient scheduling and cleaning becomes critical.
• 包装: Coated capsules, especially enteric, should be kept in 防湿梱包, as humidity can prematurely soften the film.

Troubleshooting Tips

Common problems (especially with enteric coatings) 含む:

• Coating Peeling/Flaking: Often due to poor adhesion. Causes can be an insufficient binder or too large spray droplets. 解決: ensure fine atomization, optimize polymer concentration, and possibly use adhesion promoters.
• ひび割れ: If the film cracks, acid can leak in. Typically due to drying too fast/ hot or too thick a film, causing internal stress. 解決: Reduce inlet air temperature, use plasticizers, and cure slowly.
• Inconsistent Thickness: This leads to some units releasing early. Often due to “dead spots” in the coating pan. Ensure tablets/capsules tumble uniformly (check baffles), or switch to fluid bed if needed.
• こだわり (双晶化): Especially with capsule-shaped tabs. Minimize by using anti-tacking agents (タルク) and controlling spray rate.
• Dissolution Failures: If enteric capsules fail (release too early or not at all), the issues above are likely. Use analytical tests (pH scans, microscopy) to diagnose coat uniformity.

一般的に, start by examining in-process moisture (too high makes coatings sticky), spray droplet size, and batch-to-batch consistency of excipients. 多くの coating defects can be prevented with careful validation and controls.

Choosing Between Delayed Release and Enteric Coating

To decide which is right for your product, 考慮する:

• API Sensitivity: Is the drug unstable in stomach acid? もし はい, enteric-coated is needed. If only stomach irritation is the issue (and the API survives acid), 遅延リリース (HPMC shell) might suffice.
• Target Site: Do you need release in the small intestine or beyond (例えば. for colon targeting)? Enteric is designed for intestinal delivery. Delayed release without enteric might not reach far enough.
• Speed of Onset: A delayed-release capsule still gives a burst of drug after the lag. For true gradual release, a different system would be needed.
• 配合の柔軟性: Delayed HPMC capsules allow larger fill weights and sizes; some enteric coatings require size/shape constraints. If you need a nonstandard capsule, check compatibility with coating process.
• Cost/Budget: Enteric coating adds materials and processing time, コストの増加. For tight budgets or simpler formulations, 遅延リリース (例えば. thick HPMC) may be more economical.
• 規制 & 市場: Enteric means more testing (two-stage dissolution). また, depending on region, “enteric-coated” labeling may have regulatory implications.

A quick チェックリスト:

• Is the API acid-sensitive or enzymatic (例えば. 酵素, probiotic)? → Likely Enteric-Coated.
• Is stomach upset a concern but API is stable in acid? → Maybe Delayed-Release (HPMC).
• Do you need to release in the small intestine specifically? → 腸溶コーティング.
• Do you need a cosmetic aspect (例えば. hiding taste) with just a modest delay? → 遅延リリース.
• Is Kosher/Halal certification needed? (注記: many HPMC are vegetarian; some enteric capsules are also vegetarian) → Both can meet this with the right materials.
• Are high-speed coating facilities and expertise available? そうでない場合, delayed-release may be easier to implement.

Choosing early in development is critical. Using the wrong capsule can ruin stability or dissolution and be costly to fix later. Work closely with formulation experts and equipment engineers to make the right call.

結論

要約すれば, 遅延リリース is a broad strategy (any way to postpone release), その間 腸溶性カプセル are one specific method (acid-resistant film). To design the right delayed-release capsule, first define your release target (例えば. intestinal absorption, 胃保護) and practical constraints (existing equipment, 配合特性). Then pick a route: coat the filled capsule, use a pH-sensitive shell, fill with coated pellets, or a hybrid approach. Each route will affect your capsule filling process: 例えば. pellet fills need pellet-dosing modules, enteric shells require sourcing special capsules, and coated capsules require post-fill coating.

No matter which path you take, remember to test rigorously. Dissolution in acid and buffer, fill-weight uniformity, pellet integrity, and stability are critical checkpoints. 最新のカプセル充填機 (like JinLu’s automatic capsule fillers) are quite versatile and can handle either route. They support powders, granules and pellets in hard capsules, making implementation feasible on the production floor.

If you’re evaluating delayed-release options for your product, we encourage you to send us your formulation details (カプセルサイズ, 材料, 塗りつぶしタイプ, target dose, 等). Our engineering team can then advise which approach fits best and offer sample tests on our equipment. Use the information above to frame your questions, and let us help you choose the safest, most cost-effective manufacturing route for your delayed-release capsules.

FAQs About Delayed Release vs Enteric Coated Capsules

参考文献：
1.Oral Gastro-resistant Formulations – State of the Art, Advances and Prospects: A Review —— スプリンガー ネイチャー
2.Fish Oil Containing Omega-3 Acids Delayed-Release Capsules —— 米国薬局
3.腸溶コーティングされた HPMC カプセルの in vitro 評価 - 製品性能に対する配合要素の影響 —— PMC
4.Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules —— PMC
5.Enteric coated HPMC capsules designed to achieve intestinal targeting —— PMC
6.Guidance for Industry SUPAC-MR: Modified Release Solid Oral Dosage Forms —— 私たち. 食品医薬品局